Life sciences firm PNB Vesper successfully completes Phase 2 trials of Covid-19 drug MD Bureau12 Feb 2021 12:55 PM IST"We are approaching the government for emergency use authorisation of our drug to treat the hospitalised patients in the country in a clinical trial...
AstraZeneca gets DCGI nod for Dapagliflozin tablets to treat chronic kidney disease Ruchika Sharma8 Feb 2021 11:34 AM ISTNew Delhi: AstraZeneca Pharma India on Saturday said it has received approval from the Drugs Controller General of India (DCGI) for Dapagliflozin...
Pfizer emergency use plea for Covid-19 Vaccine rejected by SEC Committee Ruchika Sharma6 Feb 2021 12:25 PM ISTNew Delhi: Just two days before pharma major Pfizer announced withdrawal of its application for emergency use authorisation of its Covid-19 vaccine in...
Dr Reddys likely to launch Sputnik V in India in March MD Bureau31 Jan 2021 11:00 AM ISTHyderabad: Dr Reddy's Laboratories Ltd hopes to launch Russian Covid vaccine Sputnik V in India in March after obtaining Emergency Use...
Covid-19 vaccines safe for those on blood thinners such as aspirin, clopidogrel: ICMR Medical Dialogues Bureau29 Jan 2021 9:30 AM ISTThe relative contraindication regarding blood thinners is mentioned in the fact sheet of both the vaccines, Covaxin and Covishield. Both Bharat...
Former AIIMS director, experts come in defense of Covid-19 vaccines- Covaxin, Covishield, slam skeptics Medical Dialogues Bureau16 Jan 2021 4:45 PM ISTNew Delhi: Slamming the skeptics for doubting the efficacy of two Covid-19 vaccines, Covishield and Covaxin, a group of 49 doctors, scientists, and...
DCGI approves Dr Reddys Phase 3 Sputnik V clinical trial in India Ruchika Sharma16 Jan 2021 12:33 PM ISTHyderabad: Dr. Reddy's Laboratories Ltd has recently announced that the company has received approval from the Drugs Control General of India (DCGI)...
Russian COVID vaccine: Sputnik V meets primary safety endpoint in Phase 2 Clinical Trial in India Ruchika Sharma12 Jan 2021 12:32 PM ISTThe safety data has been submitted to the Drugs Controller General of India (DCGI) for review and approval to continue phase 3 clinical trials.
Death of Covaxin volunteer due to cardiorespiratory failure and not related to vaccine trial, placebo: Bharat Biotech MD Bureau10 Jan 2021 11:00 AM IST"As per the post mortem report issued by the Gandhi Medical College, Bhopal, that the site received from the Bhopal Police, the probable cause of...
Masks May Never Go, warns ICMR chief Balram Bhargava Medical Dialogues Bureau10 Jan 2021 9:00 AM IST"We don't know how much of the population we'll have to vaccinate to break the virus transmission," ICMR Chief, Balram Bhargava said.
Health Ministry clarifies there is No Ban On Export Of Any Covid-19 Vaccine Medical Dialogues Bureau7 Jan 2021 5:45 PM IST"When I say Union government, it means there are three ministries, Ministry of Health, Ministry of Commerce, the Department for Promotion of Industry...
AIDAN slams approval of Covaxin, expresses alarm over lack of efficacy, trial data Farhat Nasim5 Jan 2021 4:42 PM ISTNew Delhi: Slamming the recent approval of Covid-19 vaccine, Covaxin, developed by Bharat Biotech in association with the Indian Council of...
